Full Guidance
Guidance for providing a six-month supply of oral PrEP in the form of tenofovir disoproxil + emtricitabine. In the second quarter of 2026 the Pharmaceutical Benefits Scheme (PBS) increased the number of repeats that medical and nurse practitioners can prescribe for HIV pre-exposure prophylaxis (PrEP), in the form of tenofovir disoproxil + emtricitabine. A six-month […]